《美罗培南治疗新生儿大肠埃希菌败血症的疗效及对患儿血清PCT、CRP、IL-6水平的影响.docx》由会员分享,可在线阅读,更多相关《美罗培南治疗新生儿大肠埃希菌败血症的疗效及对患儿血清PCT、CRP、IL-6水平的影响.docx(5页珍藏版)》请在第一文库网上搜索。
1、美罗培南治疗新生儿大肠埃希菌败血症的疗效及对患儿血清PCT、CRP、I16水平的影响蔡丽燕J黄斯铭J张桂花佛山市三水区人民医院新生儿科广东J弗山528100通讯作者:蔡丽燕,副主任医师,邮箱:摘要I目的观察美罗培南治疗新生儿大肠埃希菌败血症的疗效,探讨其对患儿血清降钙素原(PeT)、C反应蛋白(CRP)、白细胞介素-6(I1-6)水平的影响。方法选择2016年1月至2023年6月佛山市三水区人民医院新牛J1科收治的60例新生儿大肠埃希菌败血症患儿纳入研究,按照随机数表法分为观察组和对照组各30例。在常规治疗基础上,对照组患儿采用注射用头抱他咤治疗,观察组患儿给予注射用美罗培南治疗,两组患儿均持
2、续治疗7d。比较两组患儿治疗7d后的临床疗效、症状改善时间(拒奶改善时间、黄疸消失时间、体温正常时间)及住院时间,以及治疗前和治疗7d后的血清PCT、CRP、I1-6水平、免疫球蛋白(Ig)M、IgA的变化。结果观察组患儿的治迂总有效率为96.66%,明显高于对照组的73.33%,差异有统计学意义(尸0.05);治疗后,观察组患儿的拒奶改善时间、黄疸消失时间、体温正常时间及住院时间分别为(4.741.22)d、(6.131.28)d、(3.270.53)d、(6.781.49)d,明显短于对照组的(6.85136)d、(9.401.59)d、(5.881.06)d、(10.321.20)d,差
3、异均有统计学意义(P(11.522.71)mg1,明显低于对照组的(1.300.20)g1(7.631.51)mg/1、(17.932.40)mg1,IgMIgA水平分别为(1.36+0.15)g1(3.80+0.37)g1,明显高于对照组的(1.21+0.13)g/1、(3.150.29)g1,差异均有统计学意义(PVo.05)。结论美罗培南治疗新生儿大肠埃希菌败血症的存效明显Tir有助于降低患儿的血清PCT、CRP、I1-6水平,治疗效果明显,具有临床应用价值。【关键词】新生儿;败血症;大肠埃希菌;美罗培南;降钙素原;C反应蛋白;白细胞介素-6EffeCtOfmewenemOn1I1eon
4、ata1ESCheriChiaCo1iSePtiCemiaanditseffectonChiIdre1fSSen1mPCrCRPandI1-61eve1s.Cai1iYan,HUanRSimine,ZhanUGuihUa.DeDartmenIOfNeonaIo1ogy,SanShUiDiStriC1PeODIesHOSPita1OfFOShanCi1,FoShan528100,ChinaAbstractObjectiveToObServetheefficacyOfmeiweneminthetreatmentofneonata1ESCheriChiaCOIisepsis,and1oinvesti
5、gateitseffectOnchi1drensSerUmIeVekOfDroCaICitOnin(PCT),C-reac1iveDrOIeiIr(CRP)andinter1eukin-6(1-6).MethodsAtota1of60neonateswithescherichiaco1isepticemiaadmittedtotheDeDartmCn1Ofneonato1ogy,SanShUiDiStriCtPeop1esHoSDita1OfFOShanfromJanuary2016toJune2023werese1ectedforthisstudy,theyweredividedintoob
6、servationgroupandcontro1groupaccordingtorandomnumbertab1emethod,with30casesineachgroup.OnthebasisOfCOnVentiOna1treatment,thecontro1groupchi1drenwastreatedwithceftazidimeforinjection,andtheobservationgroupchi1drenwastreatedwithmeropenemforinjection.Thetreatment1astedfor7daysinbothgroups.Thec1inica1ef
7、ficacyataftertreatment7days,symptomimprovementtime(improvementtimeofmi1krejection,jaundicedisappearancetime,norma1temperaturetime)andhospita1StayWereComDaredbetweenIhetwogroupschi1dren,andthechangesofserumPCT,CRP,I1-61eve1s,immunog1obu1in(Ig)MandIgA1eve1satbeforeandaftertreatment7dayswerecompared.Re
8、su1tsAftertreatment,thetreatmenttota1effectiverateintheobservationgroupchi1drenwas96.66%,whichwassignificant1yhigherthanthatofthecontro1group(73.33%),thedifferenceswasstatistica11ysignificant(P0.05);aftertreatmenttheimprovementtimeofmi1krejection,jaundicedisappearancetime,norma1temperaturetimeandhos
9、pita1stayintheobservationgroupchi1drenwere(4.741.22)d,(6.131.28)d,(3.270.53)d,(6.781.49)d,whichweresignificant1yshorterthanthecontro1group(6.851.36)d,(9.401.59)d,(5.881.06)d,(10.321.20)d,thedifferenceswerestatistica11ysignificant(P0.05):aftertreatment,theserumPCT,CRP,I1-61eve1sinobservationgroupchi1
10、drenwere(0.740.16)g1,(6.181.32)mg1,(11.522.71)mg1,whichweresignificant1y1owerthanthecontro1group(I3OiO.2O)g1,(7.631.51)mg1,(17.932.40)mg1,thedifferenceswerestatistica11ysignificant(P0.05);theIgMandIgA1eve1sintheobservationgroupchi1drenwere(1.360.15)g/1and(3.8OO.37)g1,whichweresignificant1yhigherthan
11、thecontro1group(1.210.13)g/1and(3.150.29)g/1,thedifferenceswerestatistica11ysignificant(P0.05),具有可比性,见表1。木研究经医院医学伦理委员会批准。表1两组患儿的一般资料比较5s,()组别例数性别胎龄(周)体质量(kg)出生至发病时间(d)早产儿足月儿男女观察组3016(53.33)14(46.67)38.74+2.833.160.406.851.4812(40.00)18(60.00)对照组3017(56.67)13(43.33)38.80+2.613.090.486.811.6710(33.33)
12、20(66.67)Z2Zt值0.0670.0850.6140.0980.287产值0.7950.9320.5420.9220.5921.2 治疗方法两组患儿均给予常规处理,包括维持水电解质平衡、保暖、补充营养等。在常规处理基础上,对照组患儿采用注射用头电他嚏(规格1Og,厂家:齐鲁制药有限公司,H)静脉滴注,剂量每天3(MOomgkg,分23次给药J观察组皿给予注射用美罗培南(规格1.0g,厂家:石药集团欧意制药有限公司,国药准字H)静脉滴注,剂量20mgkg,2次/d(日龄W1周);20mgkg,3次/d(日龄1周)。两组患儿均持续治疗7d。1.3 观察指标与评价(检测)方法PJ临床疗效二治疗7d后评价疗效。疗效评价方法叫显效:细菌培养结果转阴,且患儿黄疸、拒奶等症状消失,CRP检测结果正常;有效:细菌培养结果转阴,且患儿黄疸、拒奶等症状有所缓解,CRP水平明显降低,但未达到正常值;无效:未满足以上标准,甚至病情加重。(2)症状改善时间及住院时间:记录两组患儿拒奶改善时间、黄疸消失时间、体温正常时间以及住院时间。(3)炎症因子:采集两组患儿治疗前、治疗7d后的空腹静脉血2m1,离心处理血清后,采用免疫荧光法测定PCT、CRP的表达,采用酷联免疫吸附法测定I1-6的表达,试剂盒均为罗氏公司提供的罗氏诊断试剂。(4)体液免疫功能:采集两组患